This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Celgene Corp (CELG)

NASDAQ: Health Care

Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) 2.00B 1.45B 1.46B 1.32B
Operating Gains/Losses 40.70M 39.90M 21.84M 36.37M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -166.30M -101.40M -30.05M -263.13M
(Increase) Decrease in Inventories -56.50M -89.70M -69.68M 70.98M
(Increase) Decrease In Other Current Assets 0.00 0.00 -1.18M 2.36M
(Decrease) Increase In Payables 252.30M 287.20M 68.19M 223.81M
(Decrease) Increase In Other Current Liabilities 39.10M 57.40M -455.49M 95.33M
(Increase) Decrease In Other Working Capital 46.30M -149.20M 98.37M -94.55M
Other Non-Cash Items 549.50M 604.30M 546.72M 143.03M
Net Cash From Continuing Operations 2.81B 2.23B 2.02B 1.81B
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 2.81B 2.23B 2.02B 1.81B
Sale of Property, Plant & Equipment 0.00 0.00 15.78M 93.19M
Cash Used for Investing Activities
Sale of Short-Term Investments 2.18B 3.64B 1.74B 2.18B
Purchases of Property, Plant & Equipment -175.10M -139.10M -160.39M -132.12M
Acquisitions -710.00M 0.00 -352.25M 0.00
Purchases of Short-Term Investments -2.66B -3.98B -2.77B -1.69B
Other Cash from Investing Activities 0.00 -1.10M -1.64M -2.00M
Cash Provided by Financing Activities
Net Cash From Investing Activities -1.44B -528.60M -1.55B 377.70M
Issuance of Debt 5.04B 5.94B 5.98B 1.88B
Cash Used for Financing Activities
Issuance of Capital Stock 307.50M 552.80M 476.23M 166.45M
Repayment of Long-Term Debt -3.01B -4.23B -4.71B -1.35B
Repurchase of Capital Stock -2.98B -2.76B -2.04B -2.22B
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 224.90M -55.60M 49.32M -125.62M
Net Cash From Financing Activities -417.40M -553.70M -248.73M -1.65B
Effect of Exchange Rate Changes -63.70M 400.00K 14.69M -23.44M
Net Change in Cash & Cash Equivalents 887.20M 1.14B 230.92M 508.34M

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for CELG

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 12 11 12 11
Moderate Buy 1 1 1 1
Hold 2 2 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

CELG Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs